News & Insights
All the latest News and Insights from OHE, plus an archive of our monthly email bulletin.
Latest Insights
Global rare‑disease policy shifts: what are the implications for equitable access to orphan medicines?
Rare diseases may affect only a small number of people, but together they impact an estimated 300–400 million people worldwide — and only around 5% have an approved treatment. As global attention grows, including the WHO’s upcoming 10-year Global Action Plan, it is important to understand how regulation, HTA, and pricing policies across the UK, EU, and US influence the development of orphan medicines and access for patients.
NICE’s new cost-effectiveness threshold: Significance, consequences, and unanswered questions
NICE’s cost-effectiveness threshold will rise in April 2026, for the first time in 20 years. This raises important questions to consider as we approach the change and in the years that follow.
Reflections from Adrian Towse on decades of HEOR research and impact
Adrian Towse, Emeritus Director and Visiting Senior Research Fellow at OHE looks back at his journey and impact in health economics research.
Turning around the NHS: Reflections on the 2025 OHE Annual Lecture
In this year’s Annual Lecture, Prof Anita Charlesworth takes a closer look at the NHS 10 Year Health Plan, concluding that all is not lost for the NHS, but questions of coherence, capacity, and capability remain.
Latest News
OHE responds to the 2025 UK Budget
Commenting on the newly announced 2025 UK Budget, Professor Graham Cookson, Chief Executive of the Office of Health Economics, said: “The NHS’ long-term sustainability will only come…
New research reveals, in carers’ own words, the multidimensional burden of caring for leukemia patients
Today, the Acute Leukemia Advocates Network (ALAN) and the Office of Health Economics (OHE published a first-of-its-kind qualitative study of informal carers across 6 countries.
New evaluation model finds widespread adoption of cell and gene therapies may unlock billions for the UK economy
A new report published today by the Cell and Gene Therapy Catapult (CGT Catapult) and the Office of Health Economics (OHE) presents a new method of quantifying the economic impact of healthcare innovations, such as cell and gene therapies.
New OHE model estimates COVID-19 could be associated with costs of £7 billion a year in the UK, without annual autumn vaccinations
A newly released report commissioned by Moderna modelled a one-year scenario without annual COVID-19 autumn vaccinations.
OHE responds to the NHS Ten Year Plan
Professor Graham Cookson responds to the Ten Year Health Plan for England.
OHE statement on 2025 Spending Review
Professor Graham Cookson responds to Chancellor’s Spending Review announcement boosting NHS spend by 3%.
